Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2009

View Archived Issues

Veltuzumab active at low doses in recurrent non-Hodgkin's lymphoma

Abeta1-15 vaccine ACI-24 shows positive safety profile in a mouse model of AD

Optimized formulation of Pronucleon peptides developed as an in vitro diagnostic tool for AD

Oral formulations of TBR-652 evaluated in healthy volunteers

ABT-089 reverses scopolamine-induced cognitive deficits in healthy volunteers

Novartis reports first results for the first half of 2009

YM-254890 shows potent bronchodilator activity in rodent models

Bristol-Myers acquires Medarex, thereby gaining rights to ipilimumab

Merck submits MAA for cladribine tablets for multiple sclerosis in Europe

Nabriva initiates phase I trial for pleuromutilin antibiotic, BC-3781

PharmaMar commences phase II Zalypsis trial in endometrial and cervical cancer

Schering-Plough files NDA for mometasone/formoterol combination for asthma

Taiho receives approval for TS-1 in Singapore

Theravance patents muscarinic receptor antagonists for the treatment of COPD and asthma

Novel PI3K inhibitors claimed by UCB for the treatment of cancer

Janssen discovers novel CB2 receptor agonists for the treatment of pain

Alcon and AstraZeneca collaborate on ophthalmic drug discovery

Takeda provides update on fixed-dose combination of alogliptin and Actos

GlaxoSmithKline completes acquisition of Stiefel

Regeneron enrolls first patient in phase III VEGF Trap-Eye program in CRVO

GSK and Enigma sign commercial partnership to develop influenza diagnostics

Peplin initiates final phase III PEP-005 gel trial in actinic keratoses

Kyowa Hakko Kirin reports results from phase III trial KW-2246 trial

AcelRx reports results from phase II study of ARX-01 Sufentanil NanoTab PCA system

Galapagos receives milestone payment under osteoporosis collaboration with Lilly

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...